WT1 and prostate cancer: In the present study, LCM and microarray analysis were used as tools to identify distinct gene expression patterns in prostate cell populations and led to the identification of genes of potential significance in prostate cancer, such as WT1. As WT1 has already been investigated as a clinical marker in acute leukemia, data demonstrating WT1 expression in prostate tumor tissues may point to its usefulness as a potential marker for prostate cancer.